Survival outcome of upfront surgery for clinical single-station N2 non-small cell lung cancer.

Takamitsu Hayakawa,Mitsuhiro Isaka,Hayato Konno,Tetsuya Mizuno,Takuya Kawata,Hirotsugu Kenmotsu,Toshiaki Takahashi,Yasuhisa Ohde

Japanese journal of clinical oncology（2023）

引用 1|浏览6

暂无评分

摘要

Clinical-skip N2 had an excellent prognosis, and upfront surgery was acceptable. Conversely, upfront surgery followed by chemotherapy is not recommended for cN2 with N1 patients because of early recurrence.

查看译文

关键词

adjuvant chemotherapy,pN2,single-station N2,skip N2,upfront surgery

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要